Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Natco Pharma , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Natco Pharma Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeNATCOPHARM
EOD Share Price605.55
Previous Share Price623.5
Price Change -17.95
Change % -2.88%
Volume186.53 K
Five Day Avg Vol115.65 K
Beta1.01186
Last Business Date27-Feb-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -57.10 -8.62
Two Weeks -68.40 -10.15
One Month -49.00 -7.49
Three Months 32.20 5.62
Six Months 63.85 11.79
One Year 30.80 5.36

Highs / Lows

DurationHighLow
One Week664.9595.35
Two Weeks684.95595.35
One Month738.1595.35
Three Months738.1560.0
Six Months738.1531.6
One Year738.1480.0

Key Moving Average

MA SMAEMA
5 Days 633.76628.173
15 Days 663.527646.648
20 Days 655.75647.688
50 Days 631.948634.192
100 Days 603.471613.064
200 Days 571.675604.228
Detailed MA Analysis of NATCOPHARM ...

Key Technical Indicators

MACD -2.11
RSI 42.12
RSI (Smooth) 37.98
ADX 18.55
Chaikin Money Flow 0.111
Williams %R -92.85
PSAR 719.62
Detailed Tech Analysis NATCOPHARM ...

Financial Data Highlights

Market Cap11054.26
Book Value/ Share202.83
Enterprise Value3337.83
Revenue TTM1915.90
Gross Profit TTM1712.70
Revenue /Share TTM105.12
Consensus Target921.86
Key Financial Highlights NATCOPHARM ...

Financial Ratios of NATCOPHARM

EPS26.68
PE22.76
Div/Share7.00
Div Yield1.12
Trailing PE22.76
Forward PE14.71
Price/Book2.99
Key Financial Ratios of NATCOPHARM ...

Key Profit & Loss Data

Period31_Mar_2019Growth
Net Inc 644.40 7.44 %
Ops Income716.00 16.96 %
Revenue2094.50 4.13 %
Ops Expense1378.50 4.23 %
PBT824.70 7.04 %
Gross Profit1712.70 1.29 %
Div Paid-110.60 38.93 %
Key P&L NATCOPHARM ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR32.655.39
Week PR69.5511.49
Month PR142.7523.57
5 Day Period24.213.92
10 Day Period25.374.01
5 Week Period69.0510.91
3 Months Period98.6816.21
Price Range /Volatility NATCOPHARM ...

Highlights & Chart Patterns of Natco Pharma Ltd.

Share has hit One Month high on 27-Feb-20.
Stock has fallen by more than 10% in last two weeks from its highest level of 684.95 dt 17-Feb-20.
Stock has fallen by more than 15% in last One Month from its highest level of 738.1 dt 10-Feb-20.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Three inside down Candlestick pattern was formed by Natco Pharma Ltd. on 25/02/2020
Bearish harami Candlestick pattern was formed by Natco Pharma Ltd. on 24/02/2020 Prior to pattern formation this share was in downtrend.
Bearish MACD line is crossed Below Zero line today
More Chart Patterns Natco Pharma Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Natco Pharma Ltd.

Date Open High Low Close Volume
27-Feb-20 623.50 628.00 595.35 605.55 186 K
26-Feb-20 630.00 635.35 621.10 623.50 74548
25-Feb-20 642.00 650.15 627.10 635.05 82442
24-Feb-20 650.10 664.90 638.00 642.05 75646
20-Feb-20 640.05 674.40 640.05 662.65 159 K
19-Feb-20 638.35 666.00 637.00 644.70 239 K
18-Feb-20 660.15 665.00 634.10 636.35 149 K
17-Feb-20 679.05 684.95 663.85 665.85 88358
14-Feb-20 675.00 684.30 668.20 676.60 209 K
13-Feb-20 670.00 677.60 655.00 673.95 902 K
About NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B, as well as is involved in the contract manufacturing activities. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF, bosentan, pulmonary arterial hypertension, and others. The company markets its products in approximately 40 countries, such as India, North America, Latin America, Asia Pacific, South East Asia, Europe, and the Middle East. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.